The transactivation domain AF-2 but not the DNA-binding domain of the estrogen receptor is required to inhibit differentiation of avian erythroid progenitors

Molecular Endocrinology

Volumn 12, Issue 2, 1998, Pages 263-277

  Von Lindern, Marieke ^a,b   Boer, Liesbeth ^a   Wessely, Oliver ^a,c   Parker, Malcolm ^a,d   Beug, Hartmut ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL RECEPTOR; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; BIRD; CELL DIFFERENTIATION; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; AVES;

EID: 0032230310     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.2.0068     Document Type: Article

References (82)

1. Long-term proliferating early pre-B cell lines and clones with the potential to develop to surface lg positive, mitogen reactive B cells
2. Insights into erythroid differentiation obtained from studies on avian erythroblastosis virus
3. EGF-R as a hemopoietic growth factor receptor: The c-erbB product is present in chicken erythrocytic progenitors and controls their self-renewal
4. The estrogen receptor cooperates with the TGF alpha receptor (c-erbB) in regulation of chicken erythroid progenitor self-renewal
5. Self-renewal and differentiation of normal avian erythroid progenitor cells: Regulatory roles of the TGF alpha/c-ErbB and SCF/c-kit receptors
6. Primary, self-renewing erythroid progenitors develop through activation of both tyrosine kinase and steroid hormone receptors
7. The glucocorticoid receptor is a key regulator of the decision between self renewal and differentiation in erythroid progenitors
8. Terminal differentiation of normal chicken erythroid progenitors: Shortening of G1 correlates with loss of D cyclin/CDK4 expression and altered cell size control
9. In vitro culture of proerythroblasts: Characterization of proliferative response to erythropoietin and steroids
10. In vitro steroid sensitivity testing: A possible means to predict response to therapy in primary hypoproliferative anemia
11. In vitro and in vivo regulation of hepatic erythropoiesis by erythropoietin and glucocorticoids in the rat fetus
12. Cytokines and estrogen in bone: Antiosteoporotic effects
13. Dopaminergic and ligand-independent activation of steroid hormone receptors
14. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3
15. Effects of estrogen and progesterone on the spleen of the mouse; A light and electron microscopic study
16. Effect of estradiol on erythropoiesis and megakaryocytopoiesis in mice
17. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone
18. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor
19. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element
20. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I
21. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity
22. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
23. Mechanism of transformation by v-rbA: Replacement of steroid hormone receptor function in self renewal induction
24. Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor
25. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1
26. Regulation and function of transcription factor GATA-1 during red blood cell differentiation
27. Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus
28. The human estrogen receptor has two independent nonacidic transcriptional activation functions
29. Identification of two transactivation domains in the mouse oestrogen receptor
30. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta
31. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
32. Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors
33. Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription
34. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
35. Characterization of ligand-dependent phosphorylation of the estrogen receptor
36. Recombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitro
37. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins
38. Temperature-sensitive v-sea transformed erythroblasts: A model system to study gene expression during erythroid differentiation
39. Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: An alteration in the DNA binding domain plays a role crucial for v-erbA function
40. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: A possible target for v-erbA oncogene action
41. v-erbA Oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA
42. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor
43. Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription
44. Interaction of proteins with transcriptionally active estrogen receptors
45. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18
46. Polarity-specific activities of retinoic acid receptors determined by a corepressor
47. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
48. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
49. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
50. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator
51. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
52. v-erbA over-expression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII
53. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist
54. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product
55. Modular structure of a chicken lysozyme silencer: Involvement of an unusual thyroid hormone receptor binding site
56. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor
57. Ligand-independant repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor
58. A transcriptional corepressor that interacts with nuclear hormone receptors
59. Steroid hormone receptors: Many actors in search of a plot
60. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1
61. Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors
62. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors
63. Commitment and activation at pol II promoters: A tail of protein-protein interactions
64. Activators and targets
65. c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene
66. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
67. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
68. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
69. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells
70. Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1
71. 9-cis-retinoic acid: Effects on normal and leukemic hematopoiesis in vitro
72. Multisubunit erythroid complexes binding to the enhancer element of the chicken histone H5 gene
73. The v-ErbA oncogene: A superb tool for dissecting the involvement of nuclear hormone receptors in differentiation and neoplasia
74. Phosphorylation of the v-erbA protein is required for its function as an oncogene
75. Avian stem cell factor (SCF): Production and characterization of the recombinant His-tagged SCF of chicken and its neutralizing antibody
76. Structural organization and expression of the mouse estrogen receptor
77. Purification and characterization of cMGF, a novel chicken myelomonocytic growth factor
78. Ts-oncogene-transformed erythroleukemic cells: A novel test system for purifying and characterizing avian erythroid growth factors
79. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
80. v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene